glp-1 and gip/glp-1 receptor agonists GIP Agonism Attenuates Receptor Agonist Induced Nausea Emesis in Preclinical Models — Hayes Lab Targeting GLP-1, GIP & GCG

People rush to the gym as soon as the new year starts to start prepping for the perfect body for summer

The triagonist-induced increase in GSIS was unchanged in the absence of either Gipr or Gcgr

Compounded medications are not FDA-approved and do not undergo FDA review for safety, effectiveness, or manufacturing quality

Learn the benefits, risks and alternatives to GLP-1 weight loss drugs from the gray market to ensure you can treat your body and mind safely.

This review summarizes current evidence on the nutritional implications of GLP1-based pharmacotherapy in adults with obesity, including common gastrointestinal adverse events, reduced energy intake, potential macro and micronutrient inadequacies, and risks of lean mass loss

Here's What You Need to Know GLP-1 receptor agonists including Wegovy (semaglutide), Ozempic (semaglutide), and Mounjaro (tirzepatide) have transformed the way millions of people manage weight and blood sugar